Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$120.92−0.42 (-0.35%)
Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –
Haemonetics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Haemonetics's operating cash flow for the twelve months ending Jun 27, 2026 was $328.15M, up 44.9% year over year. For fiscal 2026 it was $293.22M, up 61.4% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $293.22M in fiscal 2026.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $293.22M | +61.4% |
| FY2025 | Mar 29, 2025 | $181.73M | -0.0% |
| FY2024 | Mar 30, 2024 | $181.75M | -33.4% |
| FY2023 | Apr 1, 2023 | $273.06M | +58.5% |
| FY2022 | Apr 2, 2022 | $172.26M | +58.3% |
| FY2021 | Apr 3, 2021 | $108.81M | -31.2% |
| FY2020 | Mar 28, 2020 | $158.22M | -0.7% |
| FY2019 | Mar 30, 2019 | $159.28M | -27.7% |
| FY2018 | Mar 31, 2018 | $220.35M | +37.9% |
| FY2017 | Apr 1, 2017 | $159.74M | +31.1% |
| FY2016 | Apr 2, 2016 | $121.87M | -4.2% |
| FY2015 | Mar 28, 2015 | $127.18M | -8.8% |
| FY2014 | Mar 29, 2014 | $139.52M | +64.0% |
| FY2013 | Mar 30, 2013 | $85.07M | -26.2% |
| FY2012 | Mar 31, 2012 | $115.32M | -6.6% |
| FY2011 | Apr 2, 2011 | $123.46M | -5.5% |
| FY2010 | Apr 3, 2010 | $130.67M | +12.3% |
| FY2009 | Mar 28, 2009 | $116.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $52.32M | +200.8% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $70.94M | -39.1% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $93.56M | +113.8% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $111.32M | +128.0% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $17.40M | – |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $116.56M | +81.9% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $43.77M | – |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $48.82M | -50.7% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | -$27.42M | -243.7% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $64.08M | -19.5% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | -$540.00K | -100.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $99.12M | +13.9% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $19.09M | -54.5% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $79.61M | +17.0% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $64.42M | +3.2% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $87.04M | +100.3% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $41.99M | – |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $68.05M | +4298.8% |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $62.43M | -5.8% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $43.46M | +49.1% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | -$1.68M | -114.2% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | $1.55M | -96.7% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $66.29M | -16.4% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $29.16M | -2.5% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $11.81M | +349.5% |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $46.41M | +124.9% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $79.28M | +36.3% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $29.90M | -47.9% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | $2.63M | -88.6% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $20.64M | -64.2% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $58.16M | -11.1% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $57.36M | -2.6% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $23.12M | -39.8% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $57.63M | +66.7% |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $65.40M | +18.5% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $58.90M | +50.0% |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $38.43M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | $34.58M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $55.20M | – |
| Q2 FY2017CQ3 2016 | Oct 1, 2016 | $39.27M | – |
See a number that looks wrong?